About this trial
Damage to visual cortex on one side of the brain frequently produces a profound and permanent blindness in contralesional space (hemianopia), a debilitating condition that causes enormous suffering for patients and their families.
Eligibility criteria
Qualifiers
Patients will be recruited from the local subject population hospitalized/seen by Ophthalmology, Neurosurgery, and Neurology at Atrium Health Wake Forest Baptist
diagnosis of stable homonymous hemianopia (>4 weeks) with absence of hemineglect
a lesion encompassing at least primary visual cortex but sparing parietal cortex, to include lesions caused by an ischemic or hemorrhagic stroke or post-surgical changes due to an oncologic or non-oncologic tumor
normal or correctable auditory and cognitive function
Disqualifiers
diagnosis of an unstable homonymous hemianopia and/or with hemineglect,
Abnormal or uncorrectable auditory and cognitive function
unwillingness to participate in the program
inability to perform the visual testing in their intact field
Trial design
Treatments tested in this trial
- Multisensory Rehabilitation